Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT05521698. IPD Sharing: YES. Countries: 1. Publications: 0.
Therapeutic Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors
ClinicalTrials.gov study NCT03047863. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
First-in-Human Phase I/II Study of FHND-9041 in Patients With EGFR Mutated Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06521034. IPD Sharing: NO. Countries: 1. Publications: 0.
EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03542799. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib or Sacituzumab Tirumotecan for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutat
ClinicalTrials.gov study NCT07329322. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy
ClinicalTrials.gov study NCT00836160. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
ClinicalTrials.gov study NCT02283424. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Other Oncogene Mutations for Anti-EGFR Efficacy in Patients With Left-sided RAS-wild Type Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06226857. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT07267247. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC
ClinicalTrials.gov study NCT03611738. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer
ClinicalTrials.gov study NCT02272127. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib Following Chemotherapy Versus Chemotherapy as Adjuvant Therapy in Stage IIA-IIIA NSCLC With EGFR Mutation
ClinicalTrials.gov study NCT01996098. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations
ClinicalTrials.gov study NCT05445791. IPD Sharing: NO. Countries: 1. Publications: 0.
Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
ClinicalTrials.gov study NCT06784791. IPD Sharing: NO. Countries: 3. Publications: 0.
Osimertinib Combined With Bevacizumab in the Treatment Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04974879. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib for Advanced EGFR-positive NSCLC Patients
ClinicalTrials.gov study NCT05037331. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT02022995. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Andamertinib as First-line Treatment for NSCLC With EGFR PACC or EGFR L861Q Mutation
ClinicalTrials.gov study NCT07336732. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation
ClinicalTrials.gov study NCT05519293. IPD Sharing: NO. Countries: 1. Publications: 0.
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
ClinicalTrials.gov study NCT06538038. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.